Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Immunology and Allergy ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hereditary angioedema.N Engl J Med. 2020; 382: 1136-1148
- Hereditary angioedema: new findings concerning symptoms, affected organs, and course.Am J Med. 2006; 119: 267-274
- Definition and classification of hereditary angioedema.Allergy Asthma Proc. 2020; 41: S03-S07
- Hereditary angioedema with normal C1-INH (HAE type III).J Allergy Clin Immunol Pract. 2013; 1: 427-432
- Hereditary angioedema with normal C1 inhibitor: update on evaluation and treatment.Immunol Allergy Clin N Am. 2017; 37: 571-584
- The expanding spectrum of mutations in hereditary angioedema.J Allergy Clin Immunol Pract. 2021; 9: 2229-2234
- Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angioedema.Allergy. 2008; 63: 751-757
- Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema.Transfusion. 2005; 45: 1774-1784
- Unnecessary abdominal interventions in patients with hereditary angioedema.J Dtsch Dermatol Ges. 2018; 16: 1443-1449
- Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.J Allergy Clin Immunol. 2012; 130: 692-697
- The mortality from hereditary angioedema worldwide: a review of the real-world data literature.Clin Rev Allergy Immunol. 2021; 62: 232-239
- Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade.Immunol Allergy Clin N Am. 2017; 37: 513-525
- Pathophysiology of hereditary angioedema (HAE) beyond the SERPING1 gene.Clin Rev Allergy Immunol. 2021; 60: 305-315
- Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.J Allergy Clin Immunol. 2016; 138: 1414-1423
- Hereditary angioedema with a mutation in the plasminogen gene.Allergy. 2018; 73: 442-450
- Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin.Allergy. 2019; 74: 2479-2481
- Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation.J Allergy Clin Immunol. 2021; 148: 1041-1048
- Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema.J Allergy Clin Immunol. 2018; 141: 1009-1017
- A myoferlin gain-of-function variant associates with a new type of hereditary angioedema.Allergy. 2020; 75: 2989-2992
- Treatment of hereditary angioedema.J Investig Allergol Clin Immunol. 2021; 31: 1-16
- Hereditary angioedema: on-demand treatment of angioedema attacks.Allergy Asthma Proc. 2020; 41: S26-S29
- Hereditary angioedema: long-term prophylactic treatment.Allergy Asthma Proc. 2020; 41: S35-S37
- Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.J Allergy Clin Immunol. 2009; 124: 801-808
- Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.J Allergy Clin Immunol. 2010; 126: 821-827
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.N Engl J Med. 2010; 363: 532-541
- EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema.Ann Allergy Asthma Immunol. 2010; 104: 523-529
- Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.N Engl J Med. 2010; 363: 513-522
- Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor.N Engl J Med. 2017; 376: 1131-1140
- Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial.JAMA. 2018; 320: 2108-2121
- Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial.J Allergy Clin Immunol. 2021; 148: 164-172
- Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.N Engl J Med. 1976; 295: 1444-1448
- Critical appraisal of androgen use in hereditary angioedema: a systematic review.Ann Allergy Asthma Immunol. 2015; 114: 281-288
- Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients.Clin Exp Immunol. 2014; 178: 112-117
- Type III hereditary angio-oedema: clinical and biological features in a French cohort.Allergy. 2010; 65: 1331-1336
- Triggers and short-term prophylaxis in patients with hereditary angioedema.Allergy Asthma Proc. 2020; 41: S30-S34
- Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: an observational study.PLoS One. 2020; 15e0230128
- Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor: a long-term survey.Allergy. 2012; 67: 1586-1593
- International consensus on the use of genetics in the management of hereditary angioedema.J Allergy Clin Immunol Pract. 2020; 8: 901-911
- Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations.Allergy. 2015; 70: 1004-1012
- Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.J Allergy Clin Immunol. 2004; 114: S51-S131
- US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema.J Allergy Clin Immunol Pract. 2021; 9: 132-150
- The International WAO/EAACI guideline for the management of hereditary angioedema: the 2021 revision and update.Allergy. 2022;
- The International/Canadian Hereditary Angioedema Guideline.Allergy Asthma Clin Immunol. 2019; 15: 72
- An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies.Birth Defects Res B Dev Reprod Toxicol. 2009; 86: 328-344
- Exogenous hormones and hereditary angioedema.Int Immunopharmacol. 2020; 78: 106080
- Experience with intravenous plasma-derived C1-inhibitor in pregnant women with hereditary angioedema: a systematic literature review.J Allergy Clin Immunol Pract. 2020; 8: 1875-1880
- Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.Allergy Asthma Proc. 2017; 38: 216-221
- Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits.J Biotechnol. 2012; 162: 319-326
- Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.J Allergy Clin Immunol Pract. 2019; 7: 2938-2940
- Treatment of hereditary angioedema attacks with icatibant and recombinant C1 inhibitor during pregnancy.J Clin Immunol. 2018; 38: 810-815
- First report of icatibant treatment in a pregnant patient with hereditary angioedema.J Obstet Gynaecol Res. 2016; 42: 1026-1028
- Multiple doses of icatibant used during pregnancy.Allergy Rhinol (Providence). 2017; 8: 178-181
- Icatibant exposure during pregnancy in a patient with hereditary angioedema.J Investig Allergol Clin Immunol. 2015; 25: 447-449
- Icatibant [package insert].(Available at:) (Accessed January 22, 2022)
- Ecallantide [package insert].(Available at:) (Accessed January 22, 2022)
- Lanadelumab [package insert].(Available at:) (Accessed January 22, 2022)
- Berotralstat [package insert].(Available at:) (Accessed January 22, 2022)
- Ambiguous genitalia in a term female infant due to exposure to danazol in utero.Am J Dis Child. 1982; 136: 474
- Female pseudohermaphroditism due to maternal androgen administration: 25-year follow-up.Lancet. 1985; 1: 1226
- Tranexamic acid: a review of its use in surgery and other indications.Drugs. 1999; 57: 1005-1032
- Tranexamic acid [package insert].(Available at:) (Accessed January 22, 2022)
- Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.Orphanet J Rare Dis. 2018; 13: 51
- Safety and usage of C1-inhibitor in hereditary angioedema: Berinert Registry Data.J Allergy Clin Immunol Pract. 2016; 4: 963-971
- Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate.Am J Obstet Gynecol. 2010; 203: 131
- Disease expression in women with hereditary angioedema.Am J Obstet Gynecol. 2008; 199: 484
- The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.Eur J Obstet Gynecol Reprod Biol. 2010; 152: 44-49
- International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.J Allergy Clin Immunol. 2012; 129: 308-320
- Hereditary angioedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses.J Intern Med. 1996; 239: 119-130
- Management of hereditary angioedema in pregnant women: a review.Int J Womens Health. 2014; 6: 839-848
- Danazol [package insert].(Available at:) (Accessed January 22, 2022)
- Drugs and lactation Database (LactMed) [Internet]. National Library of Medicine (US), Bethesda (MD)2021 (2006–. Tranexamic Acid)
- International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.Allergy. 2017; 72: 300-313
- Complement study versus CINH gene testing for the diagnosis of type I hereditary angioedema in children.J Clin Immunol. 2016; 36: 16-18
Article info
Publication history
Published online: October 27, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
